• 文献检索
  • 文档翻译
  • 深度研究
  • 学术资讯
  • Suppr Zotero 插件Zotero 插件
  • 邀请有礼
  • 套餐&价格
  • 历史记录
应用&插件
Suppr Zotero 插件Zotero 插件浏览器插件Mac 客户端Windows 客户端微信小程序
定价
高级版会员购买积分包购买API积分包
服务
文献检索文档翻译深度研究API 文档MCP 服务
关于我们
关于 Suppr公司介绍联系我们用户协议隐私条款
关注我们

Suppr 超能文献

核心技术专利:CN118964589B侵权必究
粤ICP备2023148730 号-1Suppr @ 2026

文献检索

告别复杂PubMed语法,用中文像聊天一样搜索,搜遍4000万医学文献。AI智能推荐,让科研检索更轻松。

立即免费搜索

文件翻译

保留排版,准确专业,支持PDF/Word/PPT等文件格式,支持 12+语言互译。

免费翻译文档

深度研究

AI帮你快速写综述,25分钟生成高质量综述,智能提取关键信息,辅助科研写作。

立即免费体验

Primary antituberculous drug resistance in Hawaii, 1957 to 1977.

作者信息

Pien F D, Michael N L, Ow C L, Vennesland K, Brodsky M L

出版信息

Am Rev Respir Dis. 1978 Oct;118(4):701-4. doi: 10.1164/arrd.1978.118.4.701.

DOI:10.1164/arrd.1978.118.4.701
PMID:101107
Abstract

A study of primary antituberculous drug resistance in Hawaii was conducted from 1957 to 1977 to determine the incidence of primary resistance with respect to time. A total of 1,869 initial cultures of Mycobacterium tuberculosis submitted to Leahi Hospital in Honolulu were screened to identify drug resistance. Of 256 patients who excreted resistant bacilli, only 55 had no history of previous antituberculous chemotherapy. The frequencies of primary drug resistance from July 1957 to July 1977 were as follows: streptomycin, 0.86 per cent; isoniazid, 1.2 per cent; para-aminosalicylic acid, 1.5 per cent. No strains were resistant to ethambutol or rifampin. A slight decrease in the incidence of drug resistance during a 20-year period was observed. This was especially significant because Hawaii's tuberculosis problem is principally confined to its foreighn-born population. Although no serious primary drug resistance problem was discovered, Hawaii possesses both the highest immigration rate and the highest incidence of tuberculosis in the United states. Therefore, there is a need for continued periodic monitoring of drug resistance in Hawaii.

摘要

相似文献

1
Primary antituberculous drug resistance in Hawaii, 1957 to 1977.
Am Rev Respir Dis. 1978 Oct;118(4):701-4. doi: 10.1164/arrd.1978.118.4.701.
2
Primary drug resistance: A continuing study of tubercle bacilli in a veteran population within the United States. VI. Initial observations on the incidence of resistance to rifampin and ethambutol.原发性耐药:对美国退伍军人人群中结核杆菌的持续研究。VI. 对利福平和乙胺丁醇耐药发生率的初步观察。
Am Rev Respir Dis. 1969 May;99(5):777-9. doi: 10.1164/arrd.1969.99.5.777.
3
Incidence of resistance to primary and secondary antituberculosis drugs in isolates of M. tuberculosis from cases of pulmonary tuberculosis.肺结核病例中结核分枝杆菌分离株对一线和二线抗结核药物的耐药发生率。
Indian J Chest Dis Allied Sci. 1984 Jul-Sep;26(3):163-6.
4
Mycobacterium resistance to antimycobacterial reagent.分枝杆菌对抗分枝杆菌试剂的耐药性。
Therapie. 1999 Sep-Oct;54(5):623-5.
5
Primary drug resistance in children. Drug susceptibility of strains of Mycobacterium tuberculosis isolated from children during the years 1973 through 1977 at the Kings County Hospital Center of Brooklyn.儿童原发性耐药。1973年至1977年期间从布鲁克林国王郡医院中心的儿童中分离出的结核分枝杆菌菌株的药敏情况。
Am Rev Respir Dis. 1979 Apr;119(4):680-2. doi: 10.1164/arrd.1979.119.4.680.
6
Primary drug resistance: a continuing study of drug resistance in tuberculosis in a veteran population within the United States. IX. September 1969-September 1970.原发性耐药:对美国退伍军人人群中结核病耐药情况的持续研究。IX. 1969年9月 - 1970年9月。
Am Rev Respir Dis. 1971 Jun;103(6):842-4. doi: 10.1164/arrd.1971.103.6.842.
7
Drug resistant tuberculosis in a large southern California hospital.加利福尼亚州南部一家大型医院的耐药结核病
Am Rev Respir Dis. 1977 Nov;116(5):821-5. doi: 10.1164/arrd.1977.116.5.821.
8
Increasing drug resistance of Mycobacterium tuberculosis isolates in Ontario, Canada, 1987-1998.1987 - 1998年加拿大安大略省结核分枝杆菌分离株耐药性增加情况
Clin Infect Dis. 2000 Aug;31(2):427-32. doi: 10.1086/313969. Epub 2000 Aug 16.
9
[Interaction of antitubercular agents. I. Combined action of rifampicin, isonicotinic acid hydrazide, streptomycin and para-aminosalicylic acid on the growth of strains of tubercle bacilli].
Pneumonol Pol. 1977 Jun;45(6):425-30.
10
[Determination of resistance of Mycobacterium tuberculosis against isonicotinic acid hydrazide, streptomycin, para-aminosalicylic acid, ethionamide, ethambutol and rifampicin using the 32 P incorporation test].[使用³²P掺入试验测定结核分枝杆菌对异烟肼、链霉素、对氨基水杨酸、乙硫异烟胺、乙胺丁醇和利福平的耐药性]
Acta Biol Med Ger. 1973;30(3):309-16.

引用本文的文献

1
Evidence that rifampicin can be used safely for non-tuberculous diseases.利福平可安全用于非结核疾病的证据。
Thorax. 1980 Oct;35(10):788-91. doi: 10.1136/thx.35.10.788.